Widespread population immunity from repeated infections and updated 2025-2026 vaccines has stabilized SARS-CoV-2 circulation, making it far less likely that any emerging strain will meet the strict criteria for a new variant of concern designation before 2027. As of late April 2026, health authorities report no active variants of concern, with recent sublineages such as BA.3.2 under monitoring for immune escape mutations yet showing no surge in transmissibility, severity, or dominance over prevailing strains like XFG. Wastewater and genomic surveillance confirm steady, low-level spread without triggering public health escalations or strain replacements. Traders assign an 82.5% probability to “No” because these patterns align with the virus entering a predictable endemic phase, where only unexpected compensatory mutations or sharp case increases could shift the outlook in the remaining months.